Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.
2.

Use of cancer performance measures in population health: a macro-level perspective.

Clauser SB.

J Natl Cancer Inst Monogr. 2004;(33):142-54. Review.

PMID:
15504925
3.

A national framework for cancer surveillance in the United States.

Wingo PA, Howe HL, Thun MJ, Ballard-Barbash R, Ward E, Brown ML, Sylvester J, Friedell GH, Alley L, Rowland JH, Edwards BK.

Cancer Causes Control. 2005 Mar;16(2):151-70.

PMID:
15868456
4.
5.

Patient-reported outcomes in cancer: a review of recent research and policy initiatives.

Lipscomb J, Gotay CC, Snyder CF.

CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300. Review.

6.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
7.
8.

Five strategies for accelerating the war on cancer in an era of budget deficits.

Doroshow JH, Croyle RT, Niederhuber JE.

Oncologist. 2009 Feb;14(2):110-6. doi: 10.1634/theoncologist.2008-0270. Epub 2009 Jan 15.

9.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

11.

Health-related quality of life and symptom management research sponsored by the National Cancer Institute.

Minasian LM, O'Mara AM, Reeve BB, Denicoff AM, Kelaghan J, Rowland JH, Trimble EL; National Cancer Institute.

J Clin Oncol. 2007 Nov 10;25(32):5128-32. Review.

PMID:
17991932
12.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
13.

National Cancer Policy Board Report.

McGivney WT, Young R, Simone J.

Oncology (Williston Park). 2000 Nov;14(11A):92-6.

PMID:
11195424
14.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
15.

Dietary considerations for risk reduction.

Palmer S.

Cancer. 1986 Oct 15;58(8 Suppl):1949-53.

16.

The role of government agencies in the development of cancer policy.

Kamin DY, Daly NR.

Semin Oncol Nurs. 2002 Nov;18(4):265-75.

PMID:
12463058
17.

The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need.

Cohen HJ, Muss HB.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3606s-11s. Review.

18.

Measuring the quality of children's health care: a prerequisite to action.

Dougherty D, Simpson LA.

Pediatrics. 2004 Jan;113(1 Pt 2):185-98.

PMID:
14702501
19.
20.

Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.

McNaughton-Collins M, Walker-Corkery E, Barry MJ.

J Natl Cancer Inst Monogr. 2004;(33):78-101. Review.

PMID:
15504921

Supplemental Content

Support Center